2024-03-29T11:40:24Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_70E89F3A1C57
2024-03-23T02:31:20Z
serval:BIB_70E89F3A1C57
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
9469433
000073704800026
Valmori
D.
author
Fonteneau
J.F.
author
Lizana
C.M.
author
Gervois
N.
author
LiƩnard
D.
author
Rimoldi
D.
author
Jongeneel
V.
author
Jotereau
F.
author
Cerottini
J.C.
author
Romero
P.
author
article
1998
Journal of Immunology
0022-1767[print], 0022-1767[linking]
journal
160
4
1750-1758
Antigens, Neoplasm/immunology
Cell Line, Transformed
Cells, Cultured
Clone Cells
Cytotoxicity, Immunologic/drug effects
Epitopes, T-Lymphocyte/immunology
HLA-A Antigens/immunology
HLA-A Antigens/metabolism
Humans
Immunodominant Epitopes/immunology
Lymph Nodes/immunology
Lymph Nodes/pathology
Lymphocyte Activation/drug effects
Lymphocytes, Tumor-Infiltrating/immunology
Lymphocytes, Tumor-Infiltrating/metabolism
Melanoma/immunology
Melanoma/pathology
Neoplasm Proteins/immunology
Peptide Fragments/immunology
Peptide Fragments/metabolism
T-Lymphocytes, Cytotoxic/drug effects
T-Lymphocytes, Cytotoxic/immunology
Tumor Cells, Cultured
eng
60_published
Publication types: Journal Article ; Research Support, Non-U.S. Gov't